Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Golimumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Golimumab 50mg/0.5ml inj pre-filled disposable devices
1001030X0AAABAB
|
Golimumab | Golimumab | Musculoskeletal and Joint Diseases | 2 |
|
Simponi 100mg/1ml solution for injection pre-filled pens
1001030X0BBACAC
|
Simponi | Golimumab | Musculoskeletal and Joint Diseases | 2 |
|
Golimumab 100mg/1ml inj pre-filled disposable devices
1001030X0AAACAC
|
Golimumab | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Golimumab 50mg/0.5ml inj pre-filled syringes
1001030X0AAAAAA
|
Golimumab | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Simponi 50mg/0.5ml inj pre-filled syringes
1001030X0BBAAAA
|
Simponi | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Simponi 50mg/0.5ml solution for injection pre-filled pens
1001030X0BBABAB
|
Simponi | Golimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.